Biocytogen Pharmaceuticals Reports Quarterly Revenue of RMB461.4 Million
Story updates
08:53:16 AM UTC
SquawkNews
BIOCYTOGEN PHARMACEUTICALS BEIJING QTRLY NET PROFIT ATTRIBUTABLE RMB71.4 MLN
Related stories
Nikkei Futures Fall 1.2% to 63,955 Ahead of BOJ Decision
Nikkei futures are down 1.2% at 63,955 on SGX as investors await the Bank of Japan’s rate decision. The dollar is at 157.72 yen.
M impact | EQUITY | Oct 29, 2026, 11:46 PM UTC
Nikkei futures fall 1.4% in early trade
M impact | EQUITY | Oct 29, 2026, 11:45 PM UTC
Nasdaq Falls as Tech Earnings Disappoint
U.S. markets declined, while futures fell further after the close as more technology results disappointed. Losses extended across AI and software stocks.
M impact | EQUITY | Oct 29, 2026, 11:41 PM UTC
Google Agrees to Pay $150 Million for PG&E Connection in San Jose
Google agreed to make an up-front payment of $150 million to cover the cost of a PG&E electric connection in San Jose.
L impact | EQUITY | Oct 29, 2026, 11:40 PM UTC
Cann Group reports Q1 revenue of A$3.45 million
Cann Group reported unaudited Q1 revenue of A$3.45 million.
M impact | EQUITY | Oct 29, 2026, 11:39 PM UTC
Quaker Chemical Reports Quarterly Results
Quaker Chemical reported results for the quarter ended September 30; the supplied text provides no figures.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC